Revisiting Skeletal Dysplasias in the Newborn.


Journal

NeoReviews
ISSN: 1526-9906
Titre abrégé: Neoreviews
Pays: United States
ID NLM: 101085360

Informations de publication

Date de publication:
04 2021
Historique:
entrez: 2 4 2021
pubmed: 3 4 2021
medline: 3 11 2021
Statut: ppublish

Résumé

With over 400 reported disorders, the skeletal dysplasias represent a myriad of molecularly-based skeletal abnormalities. Arising from errors in skeletal development, the clinical spectrum of disease evolves through an affected individual's life. The naming and grouping of these disorders are ever-changing, but the fundamentals of diagnosis remain the same and are accomplished through a combination of prenatal ultrasonography and postnatal physical examination, radiography, and genetic analysis. Although some disorders are lethal in the perinatal and neonatal periods, other disorders allow survival into infancy, childhood, and even adulthood with relatively normal lives. The foundation of management for an affected individual is multidisciplinary care. Medical advances have offered new insights into reducing common morbidities through pharmacologic means. This review summarizes the normal skeletal development and discusses the 3 most common skeletal dysplasias that can affect the newborn.

Identifiants

pubmed: 33795397
pii: 22/4/e216
doi: 10.1542/neo.22-4-e216
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e216-e229

Informations de copyright

Copyright © 2021 by the American Academy of Pediatrics.

Auteurs

Seth J Langston (SJ)

Division of Neonatology, Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, CA.

Deborah Krakow (D)

Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, CA.

Alison Chu (A)

Division of Neonatology, Department of Pediatrics, University of California Los Angeles, Los Angeles, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH